NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations

Clinical trial NCT06494540 · RECRUITING

Trial details

NCT number: NCT06494540
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Non-squamous Metastatic Non-Small-Cell Lung Carcinoma

Start date: 2024-06-28
Primary completion: 2029-12-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.